PHARMIDABLE
ActiveSummary
The computed 12-month bankruptcy probability of PHARMIDABLE is 3.9% (moderate). The 2024 annual accounts show equity of €31,742 and a net result of -€28,258. Its solvency ranks better than 25% of 25,566 sector peers (NACE 47, financial year 2024). The company has been active since 2024 and the Belgian Official Gazette contains no insolvency or warning signals.
Financials · financial year 2024, micro format
2024 annual accounts filed late (64 days) Filed on 3 October 2025, deadline 31 July 2025 (7 months after the close on 31 December 2024, Companies Code art. 3:10). Source: NBB, 2025-00537936.
Turnover and EBIT margin not published: the micro format does not require them.
Peer companies
Historical observationOf the 865 companies that looked in July 2024 the way this one looks now, 1.5% went bankrupt within 24 months and 96.6% are still going.
- Small
- 2 to 5 years old
- solvency under 10%
- a small loss
A further 0.1% stopped, but we cannot tell whether within those 24 months.
For this company itself Checked computes a higher bankruptcy probability: 3.9% over twelve months. The score reads more about this company than the group's four characteristics; both figures are right about what they measure.
How reliable is this rule?
Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,445 companies of July 2024 its group's bankruptcy share. Expected: 1.6%; actually bankrupt within 24 months: 1.7%.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 3.0% | 3.1% |
| 10 | 5.6% | 6.2% |
The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 74.5% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.
An observation about 865 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.
| Line | 2024 |
|---|---|
| Remuneration, social security and pensions62 | €4,129 |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630 | €28,569 |
| Other operating charges640/8 | €1,766 |
| Gross operating margin9900 | -€6,385 |
| Operating profit (loss)9901 | -€40,850 |
| Financial income75/76B | €25,000 |
| Recurring financial income75 | €25,000 |
| Financial charges65/66B | €12,408 |
| Recurring financial charges65 | €12,408 |
| Profit (loss) for the period before taxes9903 | -€28,258 |
| Profit (loss) for the period9904 | -€28,258 |
| Profit (loss) for the period to be appropriated9905 | -€28,258 |
| Line | 2024 | |
|---|---|---|
| Assets | ||
| Total assets20/58 | €775,771 | |
| Fixed assets21/28 | €568,785 | |
| Intangible fixed assets21 | €200,468 | |
| Tangible fixed assets22/27 | €43,317 | |
| Plant, machinery and equipment23 | €29,454 | |
| Furniture and vehicles24 | €4,996 | |
| Other tangible fixed assets26 | €8,867 | |
| Financial fixed assets28 | €325,000 | |
| Current assets29/58 | €206,985 | |
| Stocks and contracts in progress3 | €61,595 | |
| Stocks30/36 | €61,595 | |
| Amounts receivable within one year40/41 | €108,045 | |
| Trade receivables40 | €63,248 | |
| Other amounts receivable41 | €44,797 | |
| Cash at bank and in hand54/58 | €37,345 | |
| Equity and liabilities | ||
| Total equity and liabilities10/49 | €775,771 | |
| Equity10/15 | €31,742 | |
| Contributions10/11 | €60,000 | |
| Profit (loss) carried forward14 | -€28,258 | |
| Amounts payable17/49 | €744,029 | |
| Amounts payable after more than one year17 | €497,436 | |
| Financial debts170/4 | €497,436 | |
| Amounts payable within one year42/48 | €236,906 | |
| Current portion of amounts payable after more than one year42 | €143,439 | |
| Trade debts44 | €93,467 | |
| Suppliers440/4 | €93,467 | |
| Taxes, remuneration and social security45 | €0 | |
| Remuneration and social security454/9 | €0 | |
| Accrued charges and deferred income492/3 | €9,687 | |
| Line | 2024 |
|---|---|
| Profit (loss) for the period9904 | -€28,258 |
| + Depreciation and write-downs630 | €28,569 |
| Operating cash flow (approximation) | €311 |
Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.
Filings with the National Bank (1)
| Financial year | Type | Filed | Reference |
|---|---|---|---|
| 31-12-2024 | micro format | 03-10-2025 | 2025-00537936 |
Similar companies · same sector, comparable size
Public contracts: No European public contracts awarded found since October 2016. Contracts below the EU thresholds are not in TED.